Dr. Arundhati Abhyankar

Employment

• Dr Bhanuben Nanavati College of Pharmacy Assistant Professor
  2019 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design
  European Journal of Medicinal Chemistry 2023 DOI: 10.1016/j.ejmech.2023.115761
  +Save
• Anti-Tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents
  Pharmaceuticals 2023 DOI: 10.3390/ph16030377
  +Save
• Atropisomerism transforming <scp>anti‐cancer</scp> drug discovery
  Chemical Biology & Drug Design 2023 DOI: 10.1111/cbdd.14155
  +Save
• Exploratory Studies on Anticancer Potential of a Vernonia Species against Colorectal Adenocarcinoma: In Vitro Studies and In Silico Mechanistic Investigations
  Medical Sciences Forum 2022 DOI: 10.3390/ECMC2022-13456
  +Save
• AN INSIGHT INTO PRIVILEGED SCAFFOLDS IN TUBERCULOSIS: DEVELOPMENTAL ASPECTS AND IMPLICATIONS IN DRUG DESIGN
  Indian Drugs 2022 DOI: 10.53879/id.59.01.13140
  +Save
• Biochemical aspects of hemoglobin-xenobiotic interactions and their implications in drug discovery
  Biochimie 2021 DOI: 10.1016/j.biochi.2021.08.006
  +Save
• DESIGN AND SYNTHESIS OF NOVEL MYCOBACTERIUM TUBERCULOSIS DHFR INHIBITORS
  International journal of pharmaceutical sciences and research 2016 DOI: 10.13040/ijpsr.0975-8232.7(6).2352-56
  +Save
• Repositioning of DHFR inhibitors
  Current Topics in Medicinal Chemistry 2016 DOI: 10.2174/1568026616666160216152540
  +Save
• Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors
  ACS Medicinal Chemistry Letters 2015 DOI: 10.1021/acsmedchemlett.5b00367
  +Save
• Rational drug design, synthesis and biological evaluation of dihydrofolate reductase inhibitors as antituberculosis agents
  Future Medicinal Chemistry 2015 DOI: 10.4155/fmc.15.48
  +Save